Your browser doesn't support javascript.
loading
FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope?
Helal, Clara; Valéry, Marine; Ducreux, Michel; Hollebecque, Antoine; Smolenschi, Cristina.
Affiliation
  • Helal C; Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France. Electronic address: clara.helal@gustaveroussy.fr.
  • Valéry M; Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France.
  • Ducreux M; Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France.
  • Hollebecque A; Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France; Department of Therapeutic Innovation and Early Trials, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
  • Smolenschi C; Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France; Department of Therapeutic Innovation and Early Trials, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France. Electronic address: cristina.smolenschi@gustaveroussy.fr.
Eur J Cancer ; 176: 168-170, 2022 11.
Article in En | MEDLINE | ID: mdl-36244195

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article